CAS: 540-82-9; Ethyl Sulfate

该化合物是一种有机化合物,其特性为由硫酸盐和乙醇衍生的酯性功能组,其特性为:它一般是一种无色的黄色液体,其色味不光彩,其色味不光彩,其色色味不光彩;该化合物以其血色特征而闻名,这意味着它可以吸收来自环境的湿气;乙酰硫酸盐在水和各种有机溶剂中溶解,使其在化学应用中具有多种用途;该化合物主要用作有机合成中的试剂,并可以用作灭菌剂;该化合物还因其潜在的毒性和腐蚀性而得到承认,需要小心处理和储存;在安全方面,该化合物被归类为一种危险物质,接触可导致皮肤,眼睛和呼吸系统受到刺激;在与该物质打交道时,适当的安全措施,包括使用个人防护设备,至关重要;

结构式图片

物理性质

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

diethyl sulfate ethanol diethyl ether etheneethyl acrylate 1,4-bisethylamino-anthraquinone diethyl sulfate ethyl chlorosulfate

合成工艺路线路线简述

  • 合成目标产物 Ethyl Hydrogen Sulphate 主要起始原料 Ethanol
  • (文献来源)合成步骤主要原料 Ethanol
📜O,O-二乙基o-氢硫代磷酸酯置于间氯过氧苯甲酸体系中,用 乙醇 作为反应溶剂,化学反应生成 硫酸单乙酯
参考文献:有机磷酸(硫代过氧)酸:直接观察和反应
标题:有机磷酸(硫代过氧)酸:直接观察和反应
摘要:有机磷酸硫代酸的过酸氧化产生了新的有机磷酸(硫代过氧)酸(psoh异构体),初步通过31 P NMR光谱证明了它们的posh异构体.这些酸或其进一步的氧化产物是磷酸化剂和磺化剂.
DOI:10.1016/0040-4039(90)87011-N

海关参考信息

专利信息


专利号:US-9969823-B1
优先权日:2011-09-01
标题 :Synthesis and polymerization of vinyl triazolium ionic liquids
发明人:LUEBKE DAVID; NULWALA HUNAID; MATYJASZEWSKI KRZYSZTOF; ADZIMA BRIAN
权利人:US ENERGY; THE US DEPARTMENT OF ENERGY
摘要:Herein, we describe polymerized ionic liquids, demonstrate the synthesis of polymerized ionic liquids, and demonstrate the polymerization of triazolium monomers. One embodiment shows the polymeriazation of the triazolium monomers with bis(trifluoromethanesulfonyl)imide anions. In another embodiment we show the feasibility of copolymerizing with commodity monomers such as styrene using free radical polymerization techniques.

专利号:EP-1638988-B1
优先权日:2003-06-30
标题:Process for the synthesis of high purity d-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpre:gn-4-ene-20-yne-3-one-oxime
发明人:TUBA ZOLTAN; MAHO SANDOR; KISS JANOS; MAGYARI ENDRENE; TERDY LASZLO
权利人:RICHTER GEDEON NYRT
摘要:The invention relates to a process for the synthesis of high purity d-(17alpha)-13-ethyl-17­hydroxy-18,19-dinorpregn-4-ene-20-yne-3-one-oxime (further on norelgestromine) via acetylation of d-norgestrel at position 17, oximation of the oxo group at position 3 of the obtained 17-acetoxy derivative, and finally hydrolyzing the acetoxy group at position 17 of the obtained 3-oxime derivative. The process according to our invention is as follows: the starting material, d-(17alpha-17-hydroxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3­one (d-norgestrel) - purity 93-94 % - is acetylated with acetic anhydride in acetic acid, in the presence of zinc chloride and hydrogen chloride, or 70 % perchloric acid in an inert gas atmosphere, and after completion of the reaction the excess of acetic anhydride and the 'enol acetate' by-product are decomposed with aqueous hydrochioric acid, then the formed d-(17alpha)-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one is isolated from the reaction mixture by addition of ice-water, the precipitated product is filtered off, washed with water, dried, dissolved in dichloromethane or acetone and clarified with silica gel or aluminum oxide and charcoal, after filtration of the clarifier the resulted solution is concentrated and the residue is recrystallized, the obtained d-(17alpha)-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one is reacted either with hydroxylammonium acetate or with hydroxylammonium chloride in the presence of sodium acetate, in acetic acid in nitrogen atmosphere under vigorous stirring for about 1 hour, after completion of the reaction water is added, the precipitated product is filtered off, washed with water, dried and recrystallized, the obtained d-(17alpha-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one-oxime is hydrolyzed with an equivalent amount of an alkali metal hydroxide in a C1-C4 alkanol solution, in nitrogen atmosphere between a temperature of about 5-38 °C, under vigorous stirring, after completion of the reaction the mixture is diluted with water and the pH of the resulted suspension is adjusted to 7,5-9 with acetic acid, the precipitated product is filtered off, washed with water, dried, the crude product is dissolved in ethanol, clarified with charcoal, and after filtration of the clarifier water is added to the obtained solution, the precipitated high purity d-(17alpha)-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one-oxime is filtered off, washed with water and in given case recrystallized from ethanol.

专利号:US-6258960-B1
优先权日:2000-03-17
标题:Catalytic asymmetric synthesis of chiral aziridines
发明人:ANTILLA JON; WULFF WILLIAM D
权利人:ARCH DEV CORP
摘要:The present invention relates to the synthesis of chiral cis-aziridines (IIIa and IIIb) by reacting an imine (I) with a diazo compound (II) in the presence of a chiral vaulted biary-Lewis Acid complex as shown below:

专利号:WO-0056708-A1
优先权日:1999-03-19
标题 :Catalytic asymmetric synthesis of chiral aziridines
发明人:WULFF WILLIAM D; ANTILLA JON
权利人:ARCH DEV CORP
摘要:The present invention relates to the synthesis of chiral cis-aziridines (IIIa and IIIb) by reacting an imine (I) with a diazo compound (II) in the presence of a chiral vaulted biaryl-Lewis Acid complex as shown.

专利号:US-4035425-A
优先权日:1973-04-23
标 题 :Synthesis of Vitamin A, intermediates and conversion thereof to Vitamin A
发明人:OROSHNIK WILLIAM
权利人:SCM CORP
摘要:A synthesis of novel Vitamin A intermediates from beta-ionone is described as well as a conversion of the intermediates to Vitamin A. The length of the conjugated aliphatic side chain of beta-ionone is increased while still ultimately obtaining the desired trans form of Vitamin A. In general, beta-ionone is ethynylated to ethynyl-beta-ionol, the hydroxyl of which is etherified to form an ethynyl-terminated, alkoxy-substituted, beta-ionol intermediate. The intermediate is coupled through its copper derivative with a compound like chloro-isopentenyl acetate to produce a C20 skeleton. By semi-hydrogenation, the acetylenic bond on the C20 skeleton is converted to an ethylenic bond, and by hydrolysis the terminal ester moiety is converted to a hydroxyl group. Treatment with a strong base removes the alkoxy group to produce Vitamin A.

专利号:US-4092366-A
优先权日:1975-04-10
标题:Synthesis of Vitamin A, intermediates and conversion thereof to Vitamin A
发明人:OROSHNIK WILLIAM
权利人:SCM CORP
摘要:A synthesis of novel Vitamin A intermediates from betaionone is described as well as a conversion of the intermediates to Vitamin A. The length of the conjugated aliphatic side chain of beta-ionone is increased while still ultimately obtaining the desired trans form of Vitamin A. In general, beta-ionone is ethynylated to ethynyl-beta-ionol, the hydroxyl of which is etherified to form an ethynyl-terminated, alkoxy-substituted, beta-ionol intermediate. The intermediate is coupled through its copper derivative with a compound like chloro-isopentenyl acetate to produce a C20 skeleton. By semi-hydrogenation, the acetylenic bond on the C20 skeleton is converted to an ethylenic bond, and by hydrolysis the terminal ester moiety is converted to a hydroxyl group. Treatment with a strong base removes the alkoxy group to produce Vitamin A.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1021/pr200310s
摘要:Manna SK, Patterson AD, Yang Q, Krausz KW, Idle JR, Fornace AJ, Gonzalez FJ. UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model. J Proteome Res. 2011 Sep 02;10(9):4120–33.
参考文献:10.1021/jp204557d
摘要:Szafrański M. Crystal Structures, Phase Transitions, and Pressure-Induced Ferroelectricity in [C(NH2)3]5SO4(SO3–OC2H5)2F. J. Phys. Chem. B. 2011 Aug 10;115(34):10277–84. doi: 10.1021/jp204557d.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知